NNVC Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
2.0M
-9.1%
2.2M
+24.3%
1.8M
-15.1%
2.1M
-5.9%
2.2M
R&D
1.3M
+15.0%
1.1M
+12.6%
993.1K
-15.7%
1.2M
-8.2%
1.3M
SG&A
744.3K
-33.2%
1.1M
+38.7%
803.6K
-14.3%
938.2K
-3.0%
966.9K
Operating Income
-2030218
+9.1%
-2233174
-24.3%
-1796685
+15.1%
-2115603
+5.9%
-2249156
EBITDA
-1900584
+9.5%
-2100091
-26.2%
-1663865
+14.9%
-1954477
+5.0%
-2057973
Net Income
-1989333
+10.4%
-2220719
-24.4%
-1785058
+14.8%
-2095881
+5.5%
-2216783
EPS (Basic)
$-0.09
+18.2%
$-0.11
-10.0%
$-0.10
+23.1%
$-0.13
+7.1%
$-0.14
EPS (Diluted)
$-0.09
+18.2%
$-0.11
-10.0%
$-0.10
+23.1%
$-0.13
+7.1%
$-0.14
Shares (Diluted)
21.6M
+8.9%
19.9M
+16.2%
17.1M
+5.8%
16.2M
+0.8%
16.0M
NanoViricides (NNVC) โ€” Financials